• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 384-398 of 1,115 results

LS0TY0Q5REENX12

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LS0TY0Q5REENX12 (U.S. Pat. App. Jan. 30, 2024)

cite Cite Document
Analyze

LP37JQ7DGREENX0

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LP37JQ7DGREENX0 (U.S. Pat. App. Nov. 17, 2023)

cite Cite Document
Analyze

LEONLYJNGREENX0

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LEONLYJNGREENX0 (U.S. Pat. App. Feb. 28, 2023)

cite Cite Document
Analyze

L6E7IH1PGREENX4

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L6E7IH1PGREENX4 (U.S. Pat. App. Aug. 3, 2022)

cite Cite Document
Analyze

LF3073V5XBLUEX5

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LF3073V5XBLUEX5 (U.S. Pat. App. Mar. 10, 2023)

cite Cite Document
Analyze

LEX88AGKXBLUEX1

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LEX88AGKXBLUEX1 (U.S. Pat. App. Mar. 7, 2023)

cite Cite Document
Analyze

LEX889UKXBLUEX4

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LEX889UKXBLUEX4 (U.S. Pat. App. Mar. 7, 2023)

cite Cite Document
Analyze

LEONLYJPGREENX0

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LEONLYJPGREENX0 (U.S. Pat. App. Feb. 28, 2023)

cite Cite Document
Analyze

LEONLYJOGREENX0

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LEONLYJOGREENX0 (U.S. Pat. App. Feb. 28, 2023)

cite Cite Document
Analyze

L0CPDAPSLDFLYX5

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L0CPDAPSLDFLYX5 (U.S. Pat. App. Mar. 4, 2022)

cite Cite Document
Analyze

L0CPDAPTLDFLYX5

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L0CPDAPTLDFLYX5 (U.S. Pat. App. Mar. 4, 2022)

cite Cite Document
Analyze

L1C5S1GTXBLUEX0

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L1C5S1GTXBLUEX0 (U.S. Pat. App. Mar. 29, 2022)

cite Cite Document
Analyze

L0CPDAPVLDFLYX5

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L0CPDAPVLDFLYX5 (U.S. Pat. App. Mar. 4, 2022)

cite Cite Document
Analyze

No. 8

Document Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 8 (N.D.W.Va. Dec. 4, 2023)

cite Cite Document
Analyze

No. 100

Document Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 100 (N.D.W.Va. Feb. 14, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 26 27 28 29 30 ... >>